New Net Neutrality Rules Went into Effect Friday, but will they Stick?

6/15/2015 Although the Federal Communications Commission (FCC) has been defeated by the courts twice before in very public fashion over the issue of net neutrality; new rules proposed by the FCC in February quietly went into effect on Friday, June 12th. This comes as a three-judge panel from the D.C. Circuit Appeals Court denied a




Will Recent ET-Plus Guardrail Settlement be Death of Trinity Industries?

6/13/2015 Tuesday’s, $663 million settlement against guardrail manufacturer Trinity industries includes the largest-ever award given to a whistle-blower under the False-Claims Act, a whopping $199 million given to former competitor, Virginian Joshua Harman. Harman sued on behalf of the government claiming that Trinity defrauded taxpayers by failing to notify the Federal Highway Administration of a


Hacked Medical Pumps Could Kill You

  6/11/2015 Billy Rios, a security expert conducting research on medical devices manufactured by Hospira, found deadly serious security flaws in drug delivery pumps. In short: hacked medical pumps could kill you. Currently, there are hundreds of thousands of Hospira pumps in hospitals throughout the U.S. I wrote a piece last month regarding an FDA


Will Amendments, Leaked TPP Pharmaceutical Revelations Sway House Voters?

6/11/2015 The House of Representatives began a two-day debate on Thursday over giving President Obama “fast-track” authorization (FTA) to negotiate the 12-country Trans-Pacific Partnership (TPP) trade agreement on behalf of the U.S., leading to a congressional vote without amendments or filibusters. Friday’s expected House vote is the final hurdle the president needs after the Senate


Bharara vs. Barra: GM Criminal Probe Intensifies

6/11/2015 It looks like the U.S. Department of Justice’s criminal investigation into General Motors’ pre-recall knowledge is tightening its grip around the company, as the agency is now considering wire fraud charges against the company. Star Manhattan U.S. Attorney, Preet Bharara, and his office are leading the investigation in conjunction with the Department of Justice.


Supreme Court Case Review may Limit Class-Action Lawsuits

6/10/2015 The U.S. Supreme Court announced on Monday, June 8th that it will be reviewing a federal appeals ruling in its next term, petitioned by Tyson Foods, challenging a $5.8 million judgment against the company over unpaid work time at an Iowa pork-processing plant. While the sum of the judgment is miniscule in cases of


FDA to consider new Class of Cholesterol Drugs

6/9/2015 A new class of cholesterol drugs will undergo a preliminary review this week from a Food and Drug Administration (FDA) advisory panel. The drugs, Amgen’s Evolocumab and Alirocumab from Sanofi SA and partner, Regeneron Pharmaceuticals, block a protein called PCSK9, which can prevent the liver from eliminating bad cholesterol. Early studies show the drugs